Ohta Y - Search Results

1

Different Clinical and Neuroimaging Characteristics in Early Stage Parkinson's Disease with Dementia and Dementia with Lewy Bodies.

Takemoto M, Sato K, Hatanaka N, Yamashita T, Ohta Y, Hishikawa N, Abe K. Takemoto M, et al. Among authors: ohta y. J Alzheimers Dis. 2016;52(1):205-11. doi: 10.3233/JAD-150952. J Alzheimers Dis. 2016. PMID: 27060948 Free PMC article.

2

Clinical Benefits of Memantine Treatment for Alzheimer's Disease in the Okayama Memantine Study II (OMS II).

Matsuzono K, Yamashita T, Ohta Y, Hishikawa N, Koike M, Sato K, Kono S, Deguchi K, Nakano Y, Abe K. Matsuzono K, et al. Among authors: ohta y. J Alzheimers Dis. 2015;47(2):487-93. doi: 10.3233/JAD-150094. J Alzheimers Dis. 2015. PMID: 26401570

3

Comprehensive Clinical Evaluations of Frontotemporal Dementia Contrasting to Alzheimer's Disease (oFTD Study).

Matsuzono K, Hishikawa N, Yamashita T, Ohta Y, Sato K, Kono S, Deguchi K, Morihara R, Abe K. Matsuzono K, et al. Among authors: ohta y. J Alzheimers Dis. 2015;48(1):279-86. doi: 10.3233/JAD-150416. J Alzheimers Dis. 2015. PMID: 26401947

4

Clinical Benefits of Rivastigmine in the Real World Dementia Clinics of the Okayama Rivastigmine Study (ORS).

Matsuzono K, Sato K, Kono S, Hishikawa N, Ohta Y, Yamashita T, Deguchi K, Nakano Y, Abe K. Matsuzono K, et al. Among authors: ohta y. J Alzheimers Dis. 2015;48(3):757-63. doi: 10.3233/JAD-150518. J Alzheimers Dis. 2015. PMID: 26402119

5

Cerebral Microbleeds in Patients with Parkinson's Disease and Dementia with Lewy Bodies: Comparison Using Magnetic Resonance Imaging and 99 mTc-ECD SPECT Subtraction Imaging.

Takemoto M, Yamashita T, Ohta Y, Tadokoro K, Omote Y, Morihara R, Abe K. Takemoto M, et al. Among authors: ohta y. J Alzheimers Dis. 2021;80(1):331-335. doi: 10.3233/JAD-201495. J Alzheimers Dis. 2021. PMID: 33523013

6

Combination Therapy of Cholinesterase Inhibitor (Donepezil or Galantamine) plus Memantine in the Okayama Memantine Study.

Matsuzono K, Hishikawa N, Ohta Y, Yamashita T, Deguchi K, Nakano Y, Abe K. Matsuzono K, et al. Among authors: ohta y. J Alzheimers Dis. 2015;45(3):771-80. doi: 10.3233/JAD-143084. J Alzheimers Dis. 2015. PMID: 25624417

7

Long-Term Efficacy of Galantamine in Alzheimer's Disease: The Okayama Galantamine Study (OGS).

Nakano Y, Matsuzono K, Yamashita T, Ohta Y, Hishikawa N, Sato K, Deguchi K, Abe K. Nakano Y, et al. Among authors: ohta y. J Alzheimers Dis. 2015;47(3):609-17. doi: 10.3233/JAD-150308. J Alzheimers Dis. 2015. PMID: 26401696

8

Clinical Benefits for Older Alzheimer's Disease Patients: Okayama Late Dementia Study (OLDS).

Matsuzono K, Yamashita T, Ohta Y, Hishikawa N, Sato K, Kono S, Deguchi K, Nakano Y, Abe K. Matsuzono K, et al. Among authors: ohta y. J Alzheimers Dis. 2015;46(3):687-93. doi: 10.3233/JAD-150175. J Alzheimers Dis. 2015. PMID: 26402513

9

Age-dependent cognitive and affective differences in Alzheimer's and Parkinson's diseases in relation to MRI findings.

Tokuchi R, Hishikawa N, Sato K, Hatanaka N, Fukui Y, Takemoto M, Ohta Y, Yamashita T, Abe K. Tokuchi R, et al. Among authors: ohta y. J Neurol Sci. 2016 Jun 15;365:3-8. doi: 10.1016/j.jns.2016.03.031. Epub 2016 Mar 29. J Neurol Sci. 2016. PMID: 27206864

10

Differences between the behavioral and psychological symptoms of Alzheimer's disease and Parkinson's disease.

Tokuchi R, Hishikawa N, Sato K, Hatanaka N, Fukui Y, Takemoto M, Ohta Y, Yamashita T, Abe K. Tokuchi R, et al. Among authors: ohta y. J Neurol Sci. 2016 Oct 15;369:278-282. doi: 10.1016/j.jns.2016.08.053. Epub 2016 Aug 25. J Neurol Sci. 2016. PMID: 27653908

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,803 results

Search Page

Filters